• The evolution of analytics

  By Peggy Brinkmann, Philip S. Borba | 20 September 2017

  Advancing technology and new data sets have allowed predictive analytics to evolve in sophistication.

• Milliman Market Monitor London - 31 August 2017

  By Neil Dissanayake | 19 September 2017

  European equity markets posted mixed results in August with geopolitical tensions leading to increased volatility during the month.

• Plan design changes improve retirement income and flexibility in defined benefit plan

  By Vicki Mazzie | 19 September 2017

  Milliman helps a company update retirement options for more flexibility.

• Measuring new business profitability under Solvency II (S2NBV)

  By Edward Morgan, Jeremy Kent | 19 September 2017

  This paper introduces a new methodology for measuring new business value and new business profitability in the Solvency II world.

• Mid-year 2017 financial results for medical professional liability specialty writers

  By Eric J. Wunder, Bradley J. Parker | 18 September 2017

  This article summarizes some key financial results for a composite of medical professional liability specialty writers through the second quarter of 2017.

• Telehealth under alternative payment models

  By Susan Philip | 13 September 2017

  Telehealth has the potential to boost the impact of population health management initiatives while improving access and convenience of healthcare delivery.

• Milliman FRM Insight: August 2017 Market Commentary

  By Joe Becker | 13 September 2017

  EM equities pushed higher in August as the rest of the world took a breather.

• Super funds: Learn more about members or risk regulatory intervention

  By Wade Matterson, Jeff Gebler | 13 September 2017

  Super funds should understand their member behaviour at a more fundamental level and funds that ignore that advice will do so at their own peril.

• Should super funds use inflation as a benchmark for retiree returns?

  By Jeff Gebler | 12 September 2017

  Inflation is an important factor to consider in portfolio construction, but the Milliman Retirement Expenditure and Profiles shows that the Consumer Price Inflation index is far from an accurate measure for retirees.

• Using prescription drug data for identifying missing diagnoses and for medical management in the Medicare Advantage market

  By Corey Nathan Berger, Brooks Conway | 12 September 2017

  Even though the Centers for Medicare and Medicaid Services does not use prescription data in assigning risk scores, Rx data can still be a valuable resource for Medicare Advantage plans.

See More Articles